---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-048065"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2024-11-27T23:59:59+00:00"
generated_at: "2026-05-29T14:52:40.130388+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vivos stockholders elect all director nominees and approve 2024 equity plan at annual meeting

## Summary
- Six directors elected: Huntsman, Green, Krammer, Lindsay, Sokolow, Thompson; each received ~1.1M for, ~155-193K withheld.
- 2024 Omnibus Equity Incentive Plan approved with 957,268 for, 313,560 against, 17,747 abstentions.
- Ratification of Moss Adams LLP as auditor for FY2024 passed with 2,496,723 for, 162,219 against, 35,623 abstentions.
- Approximately 2.7M of 4.8M outstanding shares voted, constituting a quorum.

## SEC filing metadata
- accession: 0001493152-24-048065
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2024-11-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000149315224048065/0001493152-24-048065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000149315224048065/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-048065
- JSON: https://secwatch.observer/filing/0001493152-24-048065.json
- Plain text: https://secwatch.observer/filing/0001493152-24-048065.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.